Vicente Villanueva

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Multidrug Resistant

Clinical Practice

Temporal Lobe Epilepsy

Top Venues

Neurology and therapy

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Strzelczyk, Marta Maschio, Max C Pensel, Antonietta Coppola, Satoru Takahashi, Shuichi Izumoto, Eugen Trinka, Sheri Cappucci, Ricardo Sainz-Fuertes, Vicente Villanueva
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study. Neurology and therapy 13 (3) (2024)
Jerzy P Szaflarski, Hervé Besson, Wendyl J D'Souza, Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier Salas-Puig, Victor Soto Insuga, Bernhard J Steinhoff, Adam Strzelczyk, Dimitrios Bourikas, Tony Daniels, Florin Floricel, David Friesen, Cédric Laloyaux, Vicente Villanueva
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis. Journal of neurology 271 (6) (2024)
Adam Strzelczyk, Marta Maschio, Max C Pensel, Antonietta Coppola, Satoru Takahashi, Shuichi Izumoto, Eugen Trinka, Sheri Cappucci, Ricardo Sainz-Fuertes, Vicente Villanueva
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study. Neurology and therapy 13 (3) (2024)
Mar Carreño, Antonio Gil-Nagel, José M Serratosa, Manuel Toledo, Juan Jesus Rodriguez-Uranga, Vicente Villanueva
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures. Epilepsia open 9 (3) (2024)
Adam Strzelczyk, Marta Maschio, Max C Pensel, Antonietta Coppola, Satoru Takahashi, Shuichi Izumoto, Eugen Trinka, Sheri Cappucci, Ricardo Sainz-Fuertes, Vicente Villanueva
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study. Neurology and therapy 13 (3) (2024)
Mar Carreño, Antonio Gil-Nagel, José M Serratosa, Manuel Toledo, Juan Jesus Rodriguez-Uranga, Vicente Villanueva
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures. Epilepsia open 9 (3) (2024)
Jerzy P Szaflarski, Hervé Besson, Wendyl J D'Souza, Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier Salas-Puig, Victor Soto Insuga, Bernhard J Steinhoff, Adam Strzelczyk, Dimitrios Bourikas, Tony Daniels, Florin Floricel, David Friesen, Cédric Laloyaux, Vicente Villanueva
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis. Journal of neurology (2024)
Jerzy P Szaflarski, Hervé Besson, Wendyl J D'Souza, Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier Salas-Puig, Victor Soto Insuga, Bernhard J Steinhoff, Adam Strzelczyk, Dimitrios Bourikas, Tony Daniels, Florin Floricel, David Friesen, Cédric Laloyaux, Vicente Villanueva
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis. Journal of neurology 271 (6) (2024)
Jerzy P Szaflarski, Hervé Besson, Wendyl J D'Souza, Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier Salas-Puig, Victor Soto Insuga, Bernhard J Steinhoff, Adam Strzelczyk, Dimitrios Bourikas, Tony Daniels, Florin Floricel, David Friesen, Cédric Laloyaux, Vicente Villanueva
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis. Journal of neurology 271 (6) (2024)
Adam Strzelczyk, Marta Maschio, Max C Pensel, Antonietta Coppola, Satoru Takahashi, Shuichi Izumoto, Eugen Trinka, Sheri Cappucci, Ricardo Sainz-Fuertes, Vicente Villanueva
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study. Neurology and therapy 13 (3) (2024)
Jerzy P Szaflarski, Hervé Besson, Wendyl J D'Souza, Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier Salas-Puig, Victor Soto Insuga, Bernhard J Steinhoff, Adam Strzelczyk, Dimitrios Bourikas, Tony Daniels, Florin Floricel, David Friesen, Cédric Laloyaux, Vicente Villanueva
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis. Journal of neurology 271 (6) (2024)
Adam Strzelczyk, Marta Maschio, Max C Pensel, Antonietta Coppola, Satoru Takahashi, Shuichi Izumoto, Eugen Trinka, Sheri Cappucci, Ricardo Sainz-Fuertes, Vicente Villanueva
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study. Neurology and therapy (2024)
Mar Carreño, Antonio Gil-Nagel, José M Serratosa, Manuel Toledo, Juan Jesus Rodriguez-Uranga, Vicente Villanueva
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures. Epilepsia open 9 (3) (2024)
Mar Carreño, Antonio Gil-Nagel, José M Serratosa, Manuel Toledo, Juan Jesus Rodriguez-Uranga, Vicente Villanueva
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures. Epilepsia open (2024)
Vicente Villanueva, Daniel Santos-Carrasco, Pablo Cabezudo-Garcia, Asier Gómez-Ibáñez, Mercedes Garcés, Pedro Jesús Serrano-Castro, Maria D Castro-Vilanova, Débora Sayas, Francisco J Lopez-Gonzalez, Xiana Rodríguez-Osorio, Gustavo Torres-Gaona, Rosa A Saiz-Diaz, Kevin G Hampel, Meritxell Martinez-Ferri, Maria J Aguilar-Amat, Blanca Mercedes Alvarez, Vanessa García-Morales, Ana Del Villar-Igea, Andreu Massot-Tarrús, Juan J Rodríguez-Uranga
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: outcomes from an Expanded Access Program. Epilepsia open (2023)
Vicente Villanueva, Jesús Artal, Clara-Isabel Cabeza-Alvarez, Dulce Campos, Ascensión Castillo, Gerardo Flórez, Manuel Ángel Franco-Martín, Maria Paz Garcia-Portilla, Beatriz G Giráldez, Francisco Gotor, Luis Gutiérrez-Rojas, Albert Molins Albanell, Gonzalo Paniagua, Luis Pintor-Pérez, Juan Jose Poza, Teresa Rubio-Granero, Manuel Toledo, Diego Tortosa-Conesa, Juan Rodríguez-Uranga, Julio Bobes
Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus. Neurology and therapy (2023)
Eugen Trinka, Taoufik Alsaadi, Hiroko Goji, Taketoshi Maehara, Satoru Takahashi, Julia Jacobs, Rosaria Renna, Francisco José Gil-López, Rob McMurray, Ricardo Sáinz-Fuertes, Vicente Villanueva
Perampanel for the Treatment of People with Idiopathic Generalized Epilepsy in Clinical Practice. Epilepsia (2023)
Vicente Villanueva, Cédric Laloyaux, Wendyl J D'Souza, Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier Salas-Puig, Victor Soto Insuga, Adam Strzelczyk, Jerzy P Szaflarski, Chris Chinn, Tony Daniels, Florin Floricel, David Friesen, Veronica Sendersky, Hervé Besson, Bernhard J Steinhoff
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records. CNS drugs (2023)
Judit Catalán-Aguilar, Kevin G Hampel, Irene Cano-López, Mercedes Garcés, Alejandro Lozano-García, Paula Tormos-Pons, Esperanza González-Bono, Vicente Villanueva
Prospective study of cenobamate on cognition, affectivity and quality of life in focal epilepsy. Epilepsia open (2023)
Vicente Villanueva, Daniel Santos-Carrasco, Pablo Cabezudo-Garcia, Asier Gómez-Ibáñez, Mercedes Garcés, Pedro Jesús Serrano-Castro, Maria D Castro-Vilanova, Débora Sayas, Francisco J Lopez-Gonzalez, Xiana Rodríguez-Osorio, Gustavo Torres-Gaona, Rosa A Saiz-Diaz, Kevin G Hampel, Meritxell Martinez-Ferri, Maria J Aguilar-Amat, Blanca Mercedes Alvarez, Vanessa García-Morales, Ana Del Villar-Igea, Andreu Massot-Tarrús, Juan J Rodríguez-Uranga
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program. Epilepsia open (2023)
Cecil D Hahn, Yuwu Jiang, Vicente Villanueva, Marta Zolnowska, Dimitrios Arkilo, Samuel Hsiao, Mahnaz Asgharnejad, Dennis Dlugos
A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA). Epilepsia 63 (10) (2022)
Miguel Ángel Ma Calleja-Hernández, Andrés Navarro, José María Serratosa, Manuel Toledo, Vicente Villanueva, Silvia Subías Labazuy, Alicia Gil
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain. Expert review of pharmacoeconomics & outcomes research 22 (7) (2022)
Alejandro Lozano-García, Kevin G Hampel, Antonio Gutiérrez, Vicente Villanueva, Irene Cano-López, Esperanza González-Bono
Clinical utility of Epitrack for differentiating profiles and patterns of post-surgical change in memory and quality of life in patients with drug-resistant epilepsy. Applied neuropsychology. Adult (2022)
Michael D Privitera, Hari Bhathal, Matthew Wong, Judith Helen Cross, Elaine C Wirrell, Eric D Marsh, Maria Mazurkiewicz-Beldzinska, Vicente Villanueva, Daniel Checketts, Volker Knappertz, Kevan VanLandingham
Time to onset of cannabidiol (CBD) treatment effect in Lennox-Gastaut syndrome: Analysis from two randomized controlled trials. Epilepsia 62 (5) (2021)
Vicente Villanueva, Francisco Javier López-González, José Angel Mauri, Juan Rodriguez-Uranga, Marta Olivé-Gadea, Javier Montoya, Jesus Ruiz-Giménez, Jorge Zurita, null null
BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice. Acta neurologica Scandinavica 139 (4) (2018)